Invention Grant
- Patent Title: Antiviral compounds
-
Application No.: US16165865Application Date: 2018-10-19
-
Publication No.: US11021444B2Publication Date: 2021-06-01
- Inventor: Guangyi Wang , Leonid Beigelman , Anh Truong , Carmela Napolitano , Daniele Andreotti , Haiying He , Karin Ann Stein
- Applicant: Janssen BioPharma, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Janssen BioPharma, Inc.
- Current Assignee: Janssen BioPharma, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Morrison & Foerster LLP
- Main IPC: C07D213/40
- IPC: C07D213/40 ; A61K45/06 ; A61K31/4355 ; A61K31/505 ; A61K31/427 ; A61K31/4196 ; A61K31/422 ; A61K31/4365 ; A61K31/4439 ; A61K31/4178 ; A61K31/4418 ; A61K31/4436 ; C07D491/052 ; C07D207/273 ; C07D417/12 ; C07D405/12 ; C07D401/06 ; C07D413/06 ; C07D413/12 ; C07D417/06 ; C07D409/14 ; C07D233/64 ; C07D491/048 ; C07D401/12 ; C07D213/65 ; C07D471/04 ; C07D239/34 ; C07D417/04 ; C07D413/04 ; C07D401/04 ; C07D495/14 ; C07D409/04 ; A61K31/437 ; A61K31/444 ; A61K31/4709
Abstract:
Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).
Public/Granted literature
- US20190263754A1 ANTIVIRAL COMPOUNDS Public/Granted day:2019-08-29
Information query
